Assessment of tissue viability with blood flow measurements. (2013)
Attributed to:
RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/0003319712461843
PubMed Identifier: 23913303
Publication URI: http://europepmc.org/abstract/MED/23913303
Type: Journal Article/Review
Volume: 64
Parent Publication: Angiology
Issue: 6
ISSN: 0003-3197